About Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
During the past decade, Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2020-09-23
2027-05-07
Recruiting
692
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
According to Clinical.Site data, the most researched conditions in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych" are
"B-cell Lymphoma" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych" in a lesser frequency.
Clinical Trials Intervention Types at Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
Most popular intervention types in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Abagovomab" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
The vast majority of trials in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
Currently, there are NaN active trials in "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".